Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination lipid therapy in type 2 diabetes.

Authors: K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal: Indian Heart J Date: 2014-12-24

5. ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Authors: Michele Massimo Gulizia; Furio Colivicchi; Gualtiero Ricciardi; Simona Giampaoli; Aldo Pietro Maggioni; Maurizio Averna; Maria Stella Graziani; Ferruccio Ceriotti; Alessandro Mugelli; Francesco Rossi; Gerardo Medea; Damiano Parretti; Maurizio Giuseppe Abrignani; Marcello Arca; Pasquale Perrone Filardi; Francesco Perticone; Alberico Catapano; Raffaele Griffo; Federico Nardi; Carmine Riccio; Andrea Di Lenarda; Marino Scherillo; Nicoletta Musacchio; Antonio Vittorio Panno; Giovanni Battista Zito; Mauro Campanini; Leonardo Bolognese; Pompilio Massimo Faggiano; Giuseppe Musumeci; Enrico Pusineri; Marcello Ciaccio; Enzo Bonora; Giorgio Cantelli Forti; Maria Pia Ruggieri; Claudio Cricelli; Francesco Romeo; Roberto Ferrari; Attilio Maseri
Journal: Eur Heart J Suppl Date: 2017-05-02 Impact factor: 1.803

6. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

Authors: Roberto Ferrari; Carlos Aguiar; Eduardo Alegria; Riccardo C Bonadonna; Francesco Cosentino; Moses Elisaf; Michel Farnier; Jean Ferrières; Pasquale Perrone Filardi; Nicolae Hancu; Meral Kayikcioglu; Alberto Mello E Silva; Jesus Millan; Željko Reiner; Lale Tokgozoglu; Paul Valensi; Margus Viigimaa; Michal Vrablik; Alberto Zambon; José Luis Zamorano; Alberico L Catapano
Journal: Eur Heart J Suppl Date: 2016-04-12 Impact factor: 1.803

Combination lipid therapy in type 2 diabetes.

1. Combination lipid therapy in type 2 diabetes.

Review 2. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Review 3. The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.

Review 4. Consensus statement on management of dyslipidemia in Indian subjects.

5. ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

6. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

Review 7. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Review 8. [Severe hypertriglyceridemia : Diagnostics and new treatment principles].

9. Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Review 10. Antilipidemic Drug Therapy Today and in the Future.